Iovance Biotherapeutics Inc (IOVA)

Finanzdaten der Iovance Biotherapeutics Inc-Aktie (IOVA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	39.04%99.31	71.43	86.77	67.46	59.95
Cost Of Revenue	2.58%43.60	42.50	43.11	38.48	56.66
	5.82%58.85	62.49	71.20	-	-
Research and Development	5.82%58.85	62.49	71.20	-	-
Costs And Expenses	0.82%151.22	152.47	160.23	162.36	173.73
Depreciation and Amortization	11.25%9.50	8.54	9.52	9.01	-
Operating Income/Loss	35.95%-51.91	-81.04	-73.46	-94.90	-113.77
Income/Loss From Continuing Operations Before Tax	38.92%-48.69	-79.71	-71.72	-93.66	-109.67
Income Tax Expense/Benefit, Deferred	106.47%-1.37	-0.67	0.18	-2.41	1.99
Income Tax Expense/Benefit	106.47%-1.37	-0.67	0.18	-2.41	1.99
	40.14%-47.32	-79.05	-71.90	-91.25	-111.66
Attributable To Parent	40.14%-47.32	-79.05	-71.90	-91.25	-111.66
Basic Average Shares	7.57%0.45	0.42	-	0.36	0.33
Diluted Average Shares	7.57%0.45	0.42	-	-	0.33
Basic Earnings Per Share	42.11%-0.11	-0.19	-	-0.25	-0.33
Diluted Earnings Per Share	42.11%-0.11	-0.19	-	-	-0.33